Ultrasonic tissue characterization using integrated backscatter is a non-invasive predictor of the effectiveness of beta-blocker therapy in chronic heart failure

被引：0
|
作者：
Sachiko, O [1 ]
Shinichi, N [1 ]
Chieko, F [1 ]
Kazunobu, S [1 ]
Kiyotaka, O [1 ]
Norihiro, H [1 ]
Osamu, M [1 ]
Yutaka, K [1 ]
Makoto, S [1 ]
Kuniaki, O [1 ]
机构：
[1] Tokyo Womens Med Univ, Dept Med, Daini Hosp, Tokyo, Japan
来源：
JOURNAL OF CARDIAC FAILURE | 2004年 / 10卷 / 05期
关键词：
D O I：
10.1016/j.cardfail.2004.08.058
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S169 / S169
页数：1
相关论文
共 50 条
  • [21] Tailoring beta-blocker therapy in patients with chronic heart failure utilizing NT-pro-BNP
    Johnston, N
    Green, M
    Robb, S
    Morton, I
    Dargie, H
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (06) : 144A - 144A
  • [22] ROLE OF BETA-ADRENERGIC RECEPTORS IN BETA-BLOCKER THERAPY FOR CHRONIC HEART-FAILURE IN PATIENTS WITH DILATED CARDIOMYOPATHY
    KAGIYA, T
    HORI, M
    FUKUNAMI, M
    HOKI, N
    IWAKURA, K
    KURIHARA, T
    WATANABE, Y
    KAMADA, T
    CIRCULATION, 1987, 76 (04) : 308 - 308
  • [23] Peak VO2 as a long term prognostic predictor in chronic heart failure patients on beta-blocker theraphy
    Metra, M.
    Nodari, S.
    Bordonali, T.
    Bugatti, S.
    Lombardi, C.
    Milani, P.
    Saporetti, A.
    Verzura, G.
    Parrinello, G.
    Cas, L. Dei
    EUROPEAN HEART JOURNAL, 2007, 28 : 416 - 416
  • [24] About "Resting Heart Rate Does Not Reflect the Degree of Beta-Blockade in Subjects with Heart Failure on Chronic Beta-Blocker Therapy"
    Carvalho, Vitor Oliveira
    CARDIOVASCULAR THERAPEUTICS, 2009, 27 (03) : 221 - 221
  • [25] Brain natriuretic peptide level is a predictor of efficacy, but not a sensitive marker during beta-blocker therapy for congestive heart failure
    Yoshizawa, A
    Yoshikawa, T
    Satoh, T
    Ogawa, S
    CIRCULATION, 2002, 106 (19) : 685 - 685
  • [26] Value of level of brain natriuretic peptide for risk stratification and monitoring of beta-blocker therapy in chronic heart failure
    Tumasyan, L. R.
    Nargizyan, A. B.
    Budagyan, L. G.
    Adamyan, K. G.
    EUROPEAN HEART JOURNAL, 2006, 27 : 204 - 204
  • [27] Age is not a significant risk factor for failed trial of beta-blocker therapy in older patients with chronic heart failure
    Witham, MD
    Gillespie, ND
    Struthers, AD
    AGE AND AGEING, 2004, 33 (05) : 467 - 472
  • [28] Polymorphisms of the beta-2 adrenergic receptors may influence the effects of beta-blocker therapy in the patients with chronic heart failure
    Metra, M
    Nodari, S
    Pezzali, N
    Covolo, L
    Gelatti, U
    Donato, F
    Nardi, G
    Dei Cas, L
    EUROPEAN HEART JOURNAL, 2003, 24 : 711 - 711
  • [29] Changes in collagen metabolism account for ventricular functional recovery following beta-blocker therapy in patients with chronic heart failure
    Fukui, Miho
    Goda, Akiko
    Komamura, Kazuo
    Nakabo, Ayumi
    Masaki, Mitsuru
    Yoshida, Chikako
    Hirotani, Shinichi
    Lee-Kawabata, Masaaki
    Tsujino, Takeshi
    Mano, Toshiaki
    Masuyama, Tohru
    HEART AND VESSELS, 2016, 31 (02) : 173 - 182
  • [30] Non-invasive quantitative tissue characterization of human atherosclerotic lesions in carotid and femoral arteries by ultrasound integrated backscatter
    Kawasaki, M
    Noda, T
    Takatsu, H
    Nishigaki, K
    Kunishima, A
    Hayakawa, Y
    Takamura, G
    Morita, N
    Minatoguchi, S
    Fujiwara, H
    CIRCULATION, 1998, 98 (17) : 431 - 431
12345